BioNTech Lifts Outlook Boosted by Cancer Drug Milestone Payments
BioNTech SE nudged its full-year sales outlook slightly higher boosted by milestone payments from its cancer drug partnership with Bristol Myers Squibb Co.
By Sonja Wind ยท Bloomberg
BioNTech SE nudged its full-year sales outlook slightly higher boosted by milestone payments from its cancer drug partnership with Bristol Myers Squibb Co.